<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:department>Unlisted</gtr:department><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/318B5D98-4CB4-4B10-A876-08FC93071A56"><gtr:id>318B5D98-4CB4-4B10-A876-08FC93071A56</gtr:id><gtr:name>King's College London</gtr:name><gtr:address><gtr:line1>Capital House</gtr:line1><gtr:line2>2nd Floor, Guys Campus</gtr:line2><gtr:line3>42 Weston Street</gtr:line3><gtr:line4>London</gtr:line4><gtr:postCode>SE1 3QD</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/78BB78CB-5AFD-47D0-8B86-67E92BEC868F"><gtr:id>78BB78CB-5AFD-47D0-8B86-67E92BEC868F</gtr:id><gtr:firstName>Ian</gtr:firstName><gtr:surname>Stolerman</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G9901417"><gtr:id>4A9A77F1-7333-47BE-8882-873FFAC42912</gtr:id><gtr:title>Attentional effects of nicotine</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G9901417</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2000-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>750839</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Diego (UCSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Psychiatry</gtr:department><gtr:description>Attentional effects of chronic nicotine administration</gtr:description><gtr:id>487A6919-071F-4613-8978-903D95AD8583</gtr:id><gtr:impact>Pharmacol Biochem Behav. 2007 87:360-8. Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats.
Semenova S, Stolerman IP, Markou A.</gtr:impact><gtr:outcomeId>fLd5Cb2vaBq-1</gtr:outcomeId><gtr:partnerContribution>Broadened scope of research to include additional work on chronically administered nicotine and nicotine withdrawal.</gtr:partnerContribution><gtr:piContribution>Advice on implementing the 5-choice serial reaction time task for assessing attention in rodents, based on studies carried out in London under this grant.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visits</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>804B4FE3-3360-49BE-974A-99A86FAEB239</gtr:id><gtr:impact>Numbers attending tlalks varied from about 12 to 30 - estimated numbers only as no records were kept.

Invited to speak at the same school on a second occasion.</gtr:impact><gtr:outcomeId>kV2qpJNtpxh</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2006,2007,2008</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Federation of European Neuroscience Societies</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:id>1995A309-E82B-4B44-AF2C-9687F69FB29A</gtr:id><gtr:impact>Extensive coverage in newspapers in UK, Europe, USA, Australia and Asia.

Enquiries from the general public, mostly of little relevance.</gtr:impact><gtr:outcomeId>aNn9Rysa94f</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>246113</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant (An animal model of ADHD based on prenatal alcohol and nicotine exposure)</gtr:description><gtr:end>2010-03-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>7A44BEE3-D26D-45E7-B8FE-6FCC0673B4ED</gtr:id><gtr:outcomeId>ocejYdbVdGH0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2006-09-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>7B58306F-F411-457B-B35F-96125A926DD9</gtr:id><gtr:title>Serotonin antagonists in the five-choice serial reaction time task and their interactions with nicotine.</gtr:title><gtr:parentPublicationTitle>Behavioural pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c278b2ed902a88abb1811202525fac44"><gtr:id>c278b2ed902a88abb1811202525fac44</gtr:id><gtr:otherNames>Quarta D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0955-8810</gtr:issn><gtr:outcomeId>pm_13053_23_22193593</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0047318C-0092-449E-95F0-6E804984CBA1</gtr:id><gtr:title>The serotonin 2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c278b2ed902a88abb1811202525fac44"><gtr:id>c278b2ed902a88abb1811202525fac44</gtr:id><gtr:otherNames>Quarta D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>U94hinjU6Uz</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10D509CE-E31C-4FFD-A162-297964F9B192</gtr:id><gtr:title>Different effects of ionotropic and metabotropic glutamate receptor antagonists on attention and the attentional properties of nicotine.</gtr:title><gtr:parentPublicationTitle>Neuropharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c278b2ed902a88abb1811202525fac44"><gtr:id>c278b2ed902a88abb1811202525fac44</gtr:id><gtr:otherNames>Quarta D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0028-3908</gtr:issn><gtr:outcomeId>iSAgin75Had</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2923E7F5-9035-455A-A294-06573283B357</gtr:id><gtr:title>Impaired performance of alpha7 nicotinic receptor knockout mice in the five-choice serial reaction time task.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d2670ec6665c6175c4ffa26afc77533"><gtr:id>9d2670ec6665c6175c4ffa26afc77533</gtr:id><gtr:otherNames>Hoyle E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>UPT7JjcRwQ9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C2BCF339-E13B-46F9-812A-29B2AF824339</gtr:id><gtr:title>Attentional performance of C57BL/6 and DBA/2 mice in the 5-choice serial reaction time task.</gtr:title><gtr:parentPublicationTitle>Behavioural brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c2e25a4fa01d4e26232388505f7d2e49"><gtr:id>c2e25a4fa01d4e26232388505f7d2e49</gtr:id><gtr:otherNames>Patel S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0166-4328</gtr:issn><gtr:outcomeId>gvsGEHZ5tV4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4BF0E56D-6D91-4793-B2C2-313A15D58393</gtr:id><gtr:title>Chronic nicotine administration improves attention while nicotine withdrawal induces performance deficits in the 5-choice serial reaction time task in rats.</gtr:title><gtr:parentPublicationTitle>Pharmacology, biochemistry, and behavior</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/126ddfe52c7801031633878df6b8e97d"><gtr:id>126ddfe52c7801031633878df6b8e97d</gtr:id><gtr:otherNames>Semenova S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0091-3057</gtr:issn><gtr:outcomeId>kWwwCk2rMmR</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E6E71D83-D354-4523-A920-4469438ADC14</gtr:id><gtr:title>Guidelines on nicotine dose selection for in vivo research.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/69abd65eed622ec37e47e7cf0bbe8671"><gtr:id>69abd65eed622ec37e47e7cf0bbe8671</gtr:id><gtr:otherNames>Matta SG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>n6P75Az5fi5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>215EDA30-59A6-4CD2-B26B-5F3EE6175AFC</gtr:id><gtr:title>Selective nicotinic receptor antagonists: effects on attention and nicotine-induced attentional enhancement.</gtr:title><gtr:parentPublicationTitle>Psychopharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f1b7d9705177be20429932047269b6ff"><gtr:id>f1b7d9705177be20429932047269b6ff</gtr:id><gtr:otherNames>Hahn B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0033-3158</gtr:issn><gtr:outcomeId>h8SZuNVwTio</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B48EA712-8E92-44DF-8B24-8F04A6A29311</gtr:id><gtr:title>The duration of nicotine-induced attentional enhancement in the five-choice serial reaction time task: lack of long-lasting cognitive improvement.</gtr:title><gtr:parentPublicationTitle>Behavioural pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f129da8e4d0281f6afdd40899eb33412"><gtr:id>f129da8e4d0281f6afdd40899eb33412</gtr:id><gtr:otherNames>Stolerman IP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0955-8810</gtr:issn><gtr:outcomeId>GQKtsBrLpcr</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G9901417</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>